Daniel Sandmeier Email and Phone Number

Financial analysis lead for the Transplant Diagnostic segment of Thermo Fisher with $350+M in revenue. The role covers all planning aspects of the P&L and the Balance Sheet for the division. The outlook projections include monthly forecasts to five year strategic plans. Deliver monthly senior management presentations to the Transplant Diagnostic leadership team and quarterly to the Corporate Leadership team including the global CEO. Collaborate with the sales organization on go / no go decisions for strategic quotes, to maximize margins and share gain through a managed pricing strategy.Supervision of a team of analysts supporting expense budgeting and expense management across the division.

Leading the annual planning process, regional consolidation and financial reporting for the Americas region with revenue of $3.5Bn. Providing business critical financial insights to the Americas leadership team periodically or an ad-hoc basis. Converted a post merger diverse organizational structure in a streamlined integrated reporting process. Coordinating a team of regional finance professional as part of the monthly or annual reporting across the US, Canada and LATAM. Lead and developed a team of five senior FP&A professionals across multiple geographical locations. Shaped the approach of regional finance organization collaborating with the global AECOM finance organization, enabling systematic planning processes.

Degree awarded by AICPA (US) and CIMA (UK)

Managed all budgeting, planning, and analysis processes to provide relevant financial information to the management of the bioscience business across EMEA.Oversaw the overall change management process related to planning and reporting for the EMEA region for the spin-off of Baxalta from Baxter.

Supervised the coordination, preparation, and reporting of the financial results of Baxter’s acquired Elstree facility with $40M in revenues and managed the operating costs of $16M. Coordinated the post-acquisition alignment of finance processes between entities including the supervision and coaching of the local finance team in the areas of accounting and financial reporting in accordance with the UK and US GAAP. Led the commercial finance transfer of the $635M vaccine business to Pfizer. This included negotiating and coordinating with M&A counterpart on matters such as monthly profit sharing, reporting and designing the OPEX carve-out, and the coordination of the finance activities between both companies.Led the commercial finance transfer of the $635M vaccine business to Pfizer. This included negotiating and coordinating with M&A counterpart on matters such as monthly profit sharing, reporting and designing the OPEX carve-out, and the coordination of the finance activities between both companies.Improved internal control environment by establishing new processes and best practices in the finance department, increasing financial transparency and the ability to achieve strategic goals for the facility.

In charge of due diligence activities supporting Baxter’s acquisitions as well as evaluating the assessment of the R&D pipeline where manufacturing operations were involved. In addition, the role included the coordination and consolidation of the manufacturing plant results in the Hemophilia and Immunology protein production network. The tasks required liaising with supply chain, global technical service, operations planning, and global marketing in order to ensure interplant and strategic alignment for budgeting, forecasts, capital investments, and long-term planning. Key accomplishments: Facilitating capital investment decision process on $1.8B investment, aligning ~$750M cost of goods sold planning and reporting across the global production sites, support of the R&D pipeline assessment enabling market maturity of two new product configurations.

Built and managed a team of two senior financial analysts and completed the monthly reporting and forecasting for the European bioscience plants in Belgium, Italy, and Austria.Established best practices in manufacturing accounting across the network and partnered with IT to manage a new ERP rollout. Supported the global annual budget process and was in charge of manufacturing cost calculation and monthly variance analysis.

Assisted the business unit head in establishing internal controls and monitoring tools for sales projections and tracking.

Consolidating monthly country reporting, and designing reports for the local management team and for group reporting.